Crossmark

Radiofrequency ablation is safe in patients with hepatocellular carcinoma and thrombocytopenia

Published Online: 2025-08-01

Authors

Xiao, Songchi

Wang, Xiaoze

Luo, Xuefeng
License Information

Text and Data Mining valid from 2025-08-01

Version of Record valid from 2025-08-01
More Information

Article History

Received: 29 April 2025

Revised: 1 July 2025

Accepted: 4 July 2025

First Online: 1 August 2025

Declarations

:

: The authors declare no competing interests.

Document is current